Management of Lower Respiratory Tract Infections

Current Guideline Recommendations for LRTI Management

The European Respiratory Society recommends amoxicillin or tetracycline as first-choice antibiotics for LRTIs based on proven efficacy, extensive clinical experience, and low cost 3
The European Society for Clinical Microbiology and Infectious Diseases suggests tetracycline has the additional advantage of covering Mycoplasma pneumoniae 4
In cases of hypersensitivity, the European Respiratory Society recommends macrolides (azithromycin, clarithromycin, roxithromycin) as alternatives in regions with low pneumococcal macrolide resistance 4, 3

The European Respiratory Society guidelines indicate that fluoroquinolones (levofloxacin or moxifloxacin) may be considered when clinically relevant bacterial resistance exists against first-line agents 4
Local/national resistance patterns should guide antibiotic selection, as recommended by the European Society for Clinical Microbiology and Infectious Diseases 3

Empiric antibiotic treatment should target the most common bacterial pathogens: Streptococcus pneumoniae and Haemophilus influenzae, according to the European Respiratory Society 4
For COPD exacerbations, antibiotics are indicated when patients present with increased dyspnea, increased sputum volume, and increased sputum purulence, as suggested by the European Respiratory Society 4
The European Society for Clinical Microbiology and Infectious Diseases recommends that empirical antiviral treatment for influenza is generally not recommended 3
Antiviral therapy may be considered only in high-risk patients with typical influenza symptoms present for less than 2 days during a known influenza epidemic, as recommended by the European Society for Clinical Microbiology and Infectious Diseases 3

Patients should be advised to return if symptoms persist beyond 3 weeks, according to the European Respiratory Society 6
Clinical improvement from antibiotic treatment should be expected within 3 days, as suggested by the European Respiratory Society 6
High-risk patients (elderly with comorbidities, suspected pneumonia) should be followed up within 2 days of initial assessment, as recommended by the European Society for Clinical Microbiology and Infectious Diseases 3

The European Society for Clinical Microbiology and Infectious Diseases recommends considering local antibiotic resistance patterns when selecting treatment 3
The European Respiratory Society suggests recognizing when hospital referral is necessary, especially for severely ill patients with suspected pneumonia, those failing outpatient therapy, or elderly patients with elevated risk of complications 3